Compare
Set two to ten trials or papers side by side, field by field.
Pick records with “Add to compare” on any record page, or start from one of these sets.
- KRAS G12D: the trials that reached Phase 3, and the first that stoppedAdministering Peripheral Blood Lymphocytes Transduced With a Murine T… · Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Ch… · Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus G… · Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced … · Clinical Trial of DN022150 Combined With AG Chemotherapy as First-lin…
- The three most recent KRAS trialsClinical Trial of DN022150 Combined With AG Chemotherapy as First-lin… · Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201… · TCR1188-ABC Cells in KRAS-mutated Cancers
- The three most recent early detection trialsA Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer · Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC · 64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Im…